SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
US Nuclear Corp. (UCLE) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 13/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — UCLE
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.04
Book Value / Share$0.00
Revenue / Share$0.05
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.03 |
$2.65M |
$399.42K |
15.1% |
| 2016 |
$-0.12 |
$2.1M |
$-1.61M |
-76.6% |
| 2017 |
$0.00 |
$3.07M |
$10.13K |
0.3% |
| 2018 |
$-0.15 |
$3.63M |
$-2.41M |
-66.2% |
| 2019 |
$-0.18 |
$3.54M |
$-3.22M |
-91% |
| 2020 |
$-0.18 |
$1.75M |
$-4.05M |
-230.9% |
| 2021 |
$-0.07 |
$2.14M |
$-1.89M |
-88.4% |
| 2022 |
$-0.09 |
$2.09M |
$-2.59M |
-123.8% |
| 2023 |
$-0.10 |
$2.23M |
$-3.43M |
-153.9% |
| 2024 |
$-0.04 |
$2.19M |
$-1.74M |
-79.4% |
